The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Ciprofloxacin has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Ciprofloxacin’s side effects explained” section.

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in the form of a safety-related boxed warning. The label update ...

As with other drugs, Rapamune can cause side effects. Rapamune has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the ...

Mounjaro has a boxed warning. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Side effects explained” section. Many common side ...

Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...

The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning ...